Cargando…
Different systemic rheumatic diseases as risk factors for COVID-19-related mortality
COVID-19 has been associated with increased morbidity and mortality, globally. Whether COVID-19-related mortality is increased in patients with systemic rheumatic diseases (SRDs) is still debatable. Although results are somewhat conflicting, there are a handful of nationwide studies published indica...
Autores principales: | Fragoulis, George E., Bournia, Vasiliki-Kalliopi, Sfikakis, Petros P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058744/ https://www.ncbi.nlm.nih.gov/pubmed/35499772 http://dx.doi.org/10.1007/s10067-022-06190-3 |
Ejemplares similares
-
All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015–2019
por: Bournia, Vasiliki-Kalliopi, et al.
Publicado: (2021) -
Different COVID-19 outcomes among systemic rheumatic diseases: a nation-wide cohort study
por: Bournia, Vasiliki-Kalliopi, et al.
Publicado: (2022) -
Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responses
por: Mehta, Pankti, et al.
Publicado: (2022) -
Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases
por: Fragoulis, George E, et al.
Publicado: (2022) -
COVID-19, rheumatic diseases and immune dysregulation—a perspective
por: Tariq, Shahna, et al.
Publicado: (2021)